www.fdanews.com/articles/186236-emosis-hit-diagnostic-test-approved-for-marketing-by-ec
Emosis’ HIT Diagnostic Test Approved for Marketing by EC
April 2, 2018
The European Commission granted Emosis’ heparin-induced thrombocytopenia (HIT) diagnostic test a CE Mark.
The flow cytometry-based HIT Confirm test provides results in a half hour by reading selected platelet biomarkers.
The test can contribute to the diagnosis of potentially lethal HIT in patients treated by the anticoagulant.